Xylo Technologies Ltd - Understand $xylo stock

$XYLO Market Cap: $2.72 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$167.9M

TTM

Gross Margin

15.23%

TTM

Net Earnings

-$29.26M

TTM

Current Assets

Current Liabilities

Current Ratio

Total Assets

Total Liabilities

Book Value

Cash

P/E

-0.09297

Nov 29, 2024 EST

Free Cash Flow

-$11.79M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$91.72M	$91.86M	$10.12M	$531.0K	$273.0K	$436.0K	$467.0K	$549.0K	$624.0K
YoY Change	-0.15%	807.87%	1805.46%	94.51%	-37.39%	-6.64%	-14.94%	-12.02%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$91.72M	$91.86M	$10.12M	$531.0K	$273.0K	$436.0K	$467.0K	$549.0K	$624.0K
Cost Of Revenue	$79.88M	$77.41M	$5.317M	$1.034M	$455.0K	$279.0K	$219.0K	$176.0K	$277.0K
Gross Profit	$11.84M	$14.45M	$4.801M	-$503.0K	-$182.0K	$157.0K	$248.0K	$373.0K	$347.0K
Gross Profit Margin	12.91%	15.73%	47.45%	-94.73%	-66.67%	36.01%	53.1%	67.94%	55.61%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Selling, General & Admin	$12.11M	$14.17M	$11.95M	$5.965M	$3.407M	$4.692M	$3.851M	$5.809M	$5.522M
YoY Change	-14.58%	18.59%	100.37%	75.08%	-27.39%	21.84%	-33.71%	5.2%
% of Gross Profit	102.25%	98.08%	248.95%			2988.54%	1552.82%	1557.37%	1591.35%
Research & Development	$5.888M	$4.853M	$1.045M	$997.0K	$609.0K	$1.809M	$2.208M	$3.655M	$4.384M
YoY Change	21.33%	364.4%	4.81%	63.71%	-66.33%	-18.07%	-39.59%	-16.63%
% of Gross Profit	49.73%	33.58%	21.77%			1152.23%	890.32%	979.89%	1263.4%
Depreciation & Amortization	$3.979M	$3.237M	$320.0K	$167.0K	$75.00K	$42.00K	$77.00K	$99.00K	$122.0K
YoY Change	22.92%	911.56%	91.62%	122.67%	78.57%	-45.45%	-22.22%	-18.85%
% of Gross Profit	33.6%	22.4%	6.67%			26.75%	31.05%	26.54%	35.16%
Operating Expenses	$18.00M	$19.03M	$13.00M	$6.962M	$14.11M	$6.501M	$6.059M	$9.464M	$9.903M
YoY Change	-5.42%	46.4%	86.68%	-50.67%	117.11%	7.29%	-35.98%	-4.43%
Operating Profit	-$6.155M	-$4.575M	-$8.196M	-$7.465M	-$14.30M	-$6.344M	-$5.811M	-$9.091M	-$9.556M
YoY Change	34.54%	-44.18%	9.79%	-47.78%	125.35%	9.17%	-36.08%	-4.87%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Interest Expense	-$7.528M	-$1.634M	$651.0K	$965.0K	$18.00K	$148.0K	$3.485M	$13.00K	$73.00K
YoY Change	360.71%	-351.0%	-32.54%	5261.11%	-87.84%	-95.75%	26707.69%	-82.19%
% of Operating Profit
Other Income/Expense, Net	-$1.121M	$118.0K	$494.0K	$205.0K	$99.00K	-$54.00K	$71.00K	$99.00K	$19.00K
YoY Change	-1050.0%	-76.11%	140.98%	107.07%	-283.33%	-176.06%	-28.28%	421.05%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Pretax Income	-$21.81M	-$10.10M	$4.151M	-$6.841M	-$14.18M	-$6.578M	-$2.552M	-$8.979M	-$9.464M
YoY Change	115.97%	-343.24%	-160.68%	-51.75%	115.55%	157.76%	-71.58%	-5.12%
Income Tax	-$74.00K	$111.0K	$105.0K	$9.000K	-$1.000K	$20.00K	-$7.000K	$28.00K	$68.00K
% Of Pretax Income			2.53%
Net Earnings	-$21.73M	-$10.21M	$6.794M	-$6.850M	-$14.18M	-$6.598M	-$2.545M	-$9.007M	-$9.532M
YoY Change	112.89%	-250.25%	-199.18%	-51.69%	114.88%	159.25%	-71.74%	-5.51%
Net Earnings / Revenue	-23.69%	-11.11%	67.15%	-1290.02%	-5193.41%	-1513.3%	-544.97%	-1640.62%	-1527.56%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.63	-$0.40	$16.96K	-$51.33K	-$181.5K	-$86.89K	-$132.7K	-$2.619M	-$3.400M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Short-Term Investments	$12.54M	$25.05M	$27.34M	$22.36M	$7.036M	$10.63M	$6.326M	$3.001M	$10.31M
YoY Change	-49.96%	-8.38%	22.26%	217.84%	-33.78%	67.96%	110.8%	-70.9%
Cash & Equivalents	$9.357M	$20.07M	$24.03M	$22.36M	$7.036M	$10.63M	$2.828M	$3.001M	$10.31M
Short-Term Investments	$3.179M	$4.985M	$3.315M		$0.00	$0.00	$3.498M
Other Short-Term Assets	$4.429M	$3.968M	$2.679M	$1.343M	$321.0K	$404.0K	$290.0K	$366.0K	$1.006M
YoY Change	11.62%	48.11%	99.48%	318.38%	-20.54%	39.31%	-20.77%	-63.62%
Inventory	$2.386M	$1.791M	$1.227M	$243.0K	$900.0K	$81.00K	$180.0K	$198.0K	$304.0K
Prepaid Expenses
Receivables	$12.32M	$21.45M	$408.0K	$96.00K	$22.00K	$24.00K	$18.00K	$21.00K	$254.0K
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$31.67M	$52.26M	$31.65M	$24.05M	$8.279M	$11.13M	$6.814M	$3.586M	$11.88M
YoY Change	-39.39%	65.09%	31.64%	190.43%	-25.64%	63.4%	90.02%	-69.8%
Property, Plant & Equipment	$849.0K	$999.0K	$77.00K	$449.0K	$290.0K	$105.0K	$120.0K	$178.0K	$226.0K
YoY Change	-15.02%	1197.4%	-82.85%	54.83%	176.19%	-12.5%	-32.58%	-21.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.767M	$13.14M	$18.84M	$6.193M	$4.765M	$0.00
YoY Change	-71.32%	-30.29%	204.25%	29.97%
Other Assets	$273.0K	$397.0K	$836.0K	$23.00K	$0.00	$0.00	$260.0K	$934.0K
YoY Change	-31.23%	-52.51%	3534.78%			-100.0%	-72.16%
Total Long-Term Assets	$32.23M	$45.39M	$28.08M	$8.290M	$5.055M	$105.0K	$396.0K	$1.138M	$265.0K
YoY Change	-29.01%	61.68%	238.67%	64.0%	4714.29%	-73.48%	-65.2%	329.43%
Total Assets	$63.90M	$97.65M	$59.73M	$32.34M	$13.33M	$11.24M	$7.210M	$4.724M	$12.14M
YoY Change
Accounts Payable	$13.25M	$20.42M	$702.0K	$140.0K	$75.00K	$190.0K	$190.0K	$367.0K	$358.0K
YoY Change	-35.13%	2808.97%	401.43%	86.67%	-60.53%	0.0%	-48.23%	2.51%
Accrued Expenses	$2.988M	$2.708M	$1.532M	$1.667M	$607.0K	$588.0K
YoY Change	10.34%	76.76%	-8.1%	174.63%	3.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.084M	$6.742M	$927.0K	$60.00K	$119.0K	$0.00
YoY Change	34.74%	627.29%	1445.0%	-49.58%
Total Short-Term Liabilities	$29.27M	$37.63M	$6.639M	$3.514M	$3.365M	$2.963M	$957.0K	$1.334M	$1.853M
YoY Change	-22.22%	466.76%	88.93%	4.43%	13.57%	209.61%	-28.26%	-28.01%
Long-Term Debt	$702.0K	$3.393M	$711.0K	$47.00K	$33.00K	$0.00	$0.00	$0.00	$0.00
YoY Change	-79.31%	377.22%	1412.77%	42.42%
Other Long-Term Liabilities	$26.00K	$125.0K	$711.0K	$2.580M	$1.805M	$197.0K	$742.0K	$463.0K	$107.0K
YoY Change	-79.2%	-82.42%	-72.44%	42.94%	816.24%	-73.45%	60.26%	332.71%
Total Long-Term Liabilities	$728.0K	$3.518M	$1.422M	$2.627M	$1.838M	$197.0K	$742.0K	$463.0K	$107.0K
YoY Change	-79.31%	147.4%	-45.87%	42.93%	832.99%	-73.45%	60.26%	332.71%
Total Liabilities	$40.32M	$58.51M	$10.54M	$9.374M	$6.627M	$3.160M	$1.699M	$1.797M	$1.960M
YoY Change	-31.09%	455.12%	12.44%	41.45%	109.72%	85.99%	-5.45%	-8.32%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $2.7203 Million

About XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is a IL-based company operating in Health Care Equipment & Supplies industry. Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The firm developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).

Industry: Services-Computer Processing & Data Preparation Peers: Glucotrack, Inc. Inspira Technologies OXY B.H.N. Ltd